Global COVID-19 Diagnosis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global COVID-19 Diagnosis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact.
COVID-19 Diagnosis report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global COVID-19 Diagnosis market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Hospital and Laboratory are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for COVID-19 Diagnosis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, COVID-19 Diagnosis key companies include Cepheid, Abbott, Mesa Biotech, Microsens Dx, GenMark Diagnostics and Credo, etc. Cepheid, Abbott, Mesa Biotech are top 3 players and held % share in total in 2023.
COVID-19 Diagnosis can be divided into RT-PCR, Isothermal Nucleic Acid Amplification and Others,, etc. RT-PCR is the mainstream product in the market, accounting for % share globally in 2023.
COVID-19 Diagnosis is widely used in various fields, such as Hospital and Laboratory, etc. Hospital provides greatest supports to the COVID-19 Diagnosis industry development. In 2023, global % share of COVID-19 Diagnosis went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo
Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others
Hospital
Laboratory
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COVID-19 Diagnosis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COVID-19 Diagnosis introduction, etc. COVID-19 Diagnosis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of COVID-19 Diagnosis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
COVID-19 Diagnosis report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global COVID-19 Diagnosis market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Hospital and Laboratory are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for COVID-19 Diagnosis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, COVID-19 Diagnosis key companies include Cepheid, Abbott, Mesa Biotech, Microsens Dx, GenMark Diagnostics and Credo, etc. Cepheid, Abbott, Mesa Biotech are top 3 players and held % share in total in 2023.
COVID-19 Diagnosis can be divided into RT-PCR, Isothermal Nucleic Acid Amplification and Others,, etc. RT-PCR is the mainstream product in the market, accounting for % share globally in 2023.
COVID-19 Diagnosis is widely used in various fields, such as Hospital and Laboratory, etc. Hospital provides greatest supports to the COVID-19 Diagnosis industry development. In 2023, global % share of COVID-19 Diagnosis went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo
Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others
Segment by Application
Hospital
Laboratory
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COVID-19 Diagnosis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COVID-19 Diagnosis introduction, etc. COVID-19 Diagnosis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of COVID-19 Diagnosis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.